Cargando…
The (Fab)ulous Destiny of Idarucizumab: Highlighting Its Interference with Urine Protein Immunofixation
Idarucizumab is a humanized antigen binding fragment (Fab) of a recombinant anti-dabigatran monoclonal antibody (IgG1-kappa) that allows rapid and sustained reversal of dabigatran-induced anticoagulation in case of bleeding or urgent surgery. Herein, we report a very unusual case of dabigatran rever...
Autores principales: | Gendron, Nicolas, Flament, Héloïse, Litvinova, Elena, Ortuno, Sofia, Ajzenberg, Nadine, Faille, Dorothée |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746617/ https://www.ncbi.nlm.nih.gov/pubmed/31535075 http://dx.doi.org/10.1055/s-0039-1697642 |
Ejemplares similares
-
Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
por: Melicine, Sophie, et al.
Publicado: (2023) -
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting
por: Gendron, Nicolas, et al.
Publicado: (2020) -
Application of urine immunofixation electrophoresis in prognostic evaluation of hematopoietic stem cell transplantation in patients with myeloma
por: Zhu, Shanshan, et al.
Publicado: (2022) -
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
por: de Montmollin, Etienne, et al.
Publicado: (2021) -
Destiny
Publicado: (1892)